|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Youlden DR, Cramb SM and Baade PD: The
International Epidemiology of Lung Cancer: geographical
distribution and secular trends. J Thorac Oncol. 3:819–831. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ding L, Getz G, Wheeler DA, Mardis ER,
McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan
MB, et al: Somatic mutations affect key pathways in lung
adenocarcinoma. Nature. 455:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sofocleous CT, Garg SK, Cohen P, Petre EN,
Gonen M, Erinjeri JP, Downey RJ, Travis WD and Solomon SB: Ki-67 is
an independent predictive biomarker of cancer specific and local
recurrence-free survival after lung tumor ablation. Ann Surg Oncol.
20(Suppl 3): S676–S683. 2013. View Article : Google Scholar
|
|
5
|
Warth A, Cortis J, Soltermann A, Meister
M, Budczies J, Stenzinger A, Goeppert B, Thomas M, Herth FJ,
Schirmacher P, et al: Tumour cell proliferation (Ki-67) in
non-small cell lung cancer: A critical reappraisal of its
prognostic role. Br J Cancer. 111:1222–1229. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pinsky BA and Biggins S: The spindle
checkpoint: Tension versus attachment. Trends Cell Biol.
15:486–493. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hannak E, Kirkham M, Hyman AA and Oegema
K: Aurora-A kinase is required for centrosome maturation in
Caenorhabditis elegans. J Cell Biol. 155:1109–1116. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Satinover DL, Brautigan DL and Stukenberg
PT: Aurora-A kinase and inhibitor-2 regulate the cyclin threshold
for mitotic entry in Xenopus early embryonic cell cycles. Cell
Cycle. 5:2268–2274. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Macůrek L, Lindqvist A, Lim D, Lampson MA,
Klompmaker R, Freire R, Clouin C, Taylor SS, Yaffe MB and Medema
RH: Polo-like kinase-1 is activated by aurora A to promote
checkpoint recovery. Nature. 455:119–123. 2008. View Article : Google Scholar
|
|
10
|
Mori D, Yano Y, Toyo-oka K, Yoshida N,
Yamada M, Muramatsu M, Zhang D, Saya H, Toyoshima YY, Kinoshita K,
et al: NDEL1 phosphorylation by Aurora-A kinase is essential for
centrosomal maturation, separation, and TACC3 recruitment. Mol Cell
Biol. 27:352–367. 2007. View Article : Google Scholar :
|
|
11
|
Di Fiore B, Ciciarello M and Lavia P:
Mitotic functions of the Ran GTPase network: The importance of
being in the right place at the right time. Cell Cycle. 3:305–313.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bayliss R, Sardon T, Vernos I and Conti E:
Structural basis of Aurora-A activation by TPX2 at the mitotic
spindle. Mol Cell. 12:851–862. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wong J, Lerrigo R, Jang CY and Fang G:
Aurora A regulates the activity of HURP by controlling the
accessibility of its microtubule-binding domain. Mol Biol Cell.
19:2083–2091. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Santarella RA, Koffa MD, Tittmann P, Gross
H and Hoenger A: HURP wraps microtubule ends with an additional
tubulin sheet that has a novel conformation of tubulin. J Mol Biol.
365:1587–1595. 2007. View Article : Google Scholar
|
|
15
|
Yu CT, Hsu JM, Lee YC, Tsou AP, Chou CK
and Huang CY: Phosphorylation and stabilization of HURP by
Aurora-A: Implication of HURP as a transforming target of Aurora-A.
Mol Cell Biol. 25:5789–5800. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Blangy A, Lane HA, d'Hérin P, Harper M,
Kress M and Nigg EA: Phosphorylation by p34cdc2 regulates spindle
association of human Eg5, a kinesin-related motor essential for
bipolar spindle formation in vivo. Cell. 83:1159–1169. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma N, Tulu US, Ferenz NP, Fagerstrom C,
Wilde A and Wadsworth P: Poleward transport of TPX2 in the
mammalian mitotic spindle requires dynein, Eg5, and microtubule
flux. Mol Biol Cell. 21:979–988. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cassimeris L and Morabito J: TOGp, the
human homolog of XMAP215/Dis1, is required for centrosome
integrity, spindle pole organization, and bipolar spindle assembly.
Mol Biol Cell. 15:1580–1590. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Barr AR and Gergely F: MCAK-independent
functions of ch-Tog/XMAP215 in microtubule plus-end dynamics. Mol
Cell Biol. 28:7199–7211. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koffa MD, Casanova CM, Santarella R,
Köcher T, Wilm M and Mattaj IW: HURP is part of a Ran-dependent
complex involved in spindle formation. Curr Biol. 16:743–754. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chinn DC, Holland WS and Mack PC:
Anticancer activity of the Aurora A kinase inhibitor MK-5108 in
non-small-cell lung cancer (NSCLC) in vitro as monotherapy and in
combination with chemotherapies. J Cancer Res Clin Oncol.
140:1137–1149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Goldenson B and Crispino JD: The aurora
kinases in cell cycle and leukemia. Oncogene. 34:537–545. 2015.
View Article : Google Scholar
|
|
23
|
Melichar B, Adenis A, Lockhart AC,
Bennouna J, Dees EC, Kayaleh O, Obermannova R, DeMichele A,
Zatloukal P, Zhang B, et al: Safety and activity of alisertib, an
investigational aurora kinase A inhibitor, in patients with breast
cancer, small-cell lung cancer, non-small-cell lung cancer, head
and neck squamous-cell carcinoma, and gastro-oesophageal
adenocarcinoma: A five-arm phase 2 study. Lancet Oncol. 16:395–405.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Martens-de Kemp SR1, Nagel R, Stigter-van
Walsum M, van der Meulen IH, van Beusechem VW, Braakhuis BJ and
Brakenhoff RH: Functional genetic screens identify genes essential
for tumor cell survival in head and neck and lung cancer. Clin
Cancer Res. 19:1994–2003. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Beasley MB, Brambilla E and Travis WD: The
2004 World Health Organization classification of lung tumors. Semin
Roentgenol. 40:90–97. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wittekind C: 2010 TNM system: On the 7th
edition of TNM classification of malignant tumors. Pathologe.
31:331–332. 2010.In German. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schneider MA, Granzow M, Warth A, Schnabel
PA, Thomas M, Herth FJ, Dienemann H, Muley T and Meister M:
Glycodelin: A new biomarker with immunomodulatory functions in
non-small cell lung cancer. Clin Cancer Res. 21:3529–3540. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bustin SA, Benes V, Garson JA, Hellemans
J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL,
et al: The MIQE guidelines: Minimum information for publication of
quantitative real-time PCR experiments. Clin Chem. 55:611–622.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
McShane LM, Altman DG, Sauerbrei W, Taube
SE, Gion M and Clark GM: Statistics Subcommittee of the NCI-EORTC
Working Group on Cancer Diagnostics REporting recommendations for
tumour MARKer prognostic studies (REMARK). Eur J Cancer.
41:1690–1696. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dinse GE and Lagakos SW: Nonparametric
estimation of lifetime and disease onset distributions from
incomplete observations. Biometrics. 38:921–932. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mann HB and Whitney DR: On a test whether
one of two random variables is stochastically larger than the
other. Ann Math Stat. 18:50–60. 1947. View Article : Google Scholar
|
|
32
|
Kruskal WH and Wallis WA: Use of ranks in
one-criterion variance analysis. J Am Stat Assoc. 47:583–621. 1952.
View Article : Google Scholar
|
|
33
|
Fieller EC, Hartley HO and Pearson ES:
Tests for rank correlation coefficients I. Biometrika. 44:470–481.
1957. View Article : Google Scholar
|
|
34
|
Budczies J, Klauschen F, Sinn BV, Győrffy
B, Schmitt WD, Darb-Esfahani S and Denkert C: Cutoff Finder: A
comprehensive and straightforward Web application enabling rapid
biomarker cutoff optimization. PLoS One. 7:e518622012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fu J, Bian M, Xin G, Deng Z, Luo J, Guo X,
Chen H, Wang Y, Jiang Q and Zhang C: TPX2 phosphorylation maintains
metaphase spindle length by regulating microtubule flux. J Cell
Biol. 210:373–383. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li Y, Tang H, Sun Z, Bungum AO, Edell ES,
Lingle WL, Stoddard SM, Zhang M, Jen J, Yang P, et al:
Network-based approach identified cell cycle genes as predictor of
overall survival in lung adenocarcinoma patients. Lung Cancer.
80:91–98. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen L, Zhuo D, Chen J and Yuan H:
Screening feature genes of lung carcinoma with DNA microarray
analysis. Int J Clin Exp Med. 8:12161–12171. 2015.PubMed/NCBI
|
|
38
|
Eguchi T, Kadota K, Chaft J, Evans B, Kidd
J, Tan KS, Dycoco J, Kolquist K, Davis T, Hamilton SA, et al: Cell
cycle progression score is a marker for five-year lung
cancer-specific mortality risk in patients with resected stage I
lung adenocarcinoma. Oncotarget. 7:35241–35256. 2016.PubMed/NCBI
|
|
39
|
Cuzick J, Swanson GP, Fisher G, Brothman
AR, Berney DM, Reid JE, Mesher D, Speights VO, Stankiewicz E,
Foster CS, et al Transatlantic Prostate Group: Prognostic value of
an RNA expression signature derived from cell cycle proliferation
genes in patients with prostate cancer: A retrospective study.
Lancet Oncol. 12:245–255. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wistuba II, Behrens C, Lombardi F, Wagner
S, Fujimoto J, Raso MG, Spaggiari L, Galetta D, Riley R, Hughes E,
et al: Validation of a proliferation-based expression signature as
prognostic marker in early stage lung adenocarcinoma. Clin Cancer
Res. 19:6261–6271. 2013. View Article : Google Scholar : PubMed/NCBI
|
